OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint Corporate Broker and Joint ...

Operator Greetings, everyone, and welcome to Lumen Technologies' fourth quarter and full year 2024 earnings call. During the ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

Ladies and gentlemen, welcome to the Cognizant Technology Solutions' Fourth Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the ...

Q4 2024 Earnings Conference Call February 5, 2025 4:25 PM ET. Company Participants. Stan Finkelstein - VP of Investor Relations Mike Slessor - Chief ...